SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 3,351.75 |
| Enterprise Value ($M) | 3,296.85 |
| Book Value ($M) | 539.11 |
| Book Value / Share | 6.92 |
| Price / Book | 6.22 |
| NCAV ($M) | 477.91 |
| NCAV / Share | 6.13 |
| Price / NCAV | 7.01 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.36 |
| Return on Assets (ROA) | -0.68 |
| Return on Equity (ROE) | -0.68 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 13.07 |
| Current Ratio | 13.07 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 574.15 |
| Assets | 635.35 |
| Liabilities | 96.25 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 4.01 |
| Operating Income | -222.61 |
| Net Income | -214.53 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -166.31 |
| Cash from Investing | -200.41 |
| Cash from Financing | 388.94 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | EcoR1 Capital, LLC | 5.30 | ||
| 13D/A | Perceptive Advisors Llc | 1.90 | -72.09 | |
| 13G/A | Driehaus Capital Management Llc | 7.54 | -10.41 | |
| 13G/A | Braidwell Lp | 0.00 | -100.00 | |
| 13G/A | Point72 Asset Management, L.P. | 5.10 | -8.34 | |
| 13G/A | Biotechnology Value Fund L P | 0.00 | -100.00 | |
| 13G/A | Orbimed Advisors Llc | 2.50 | -47.84 | |
| 13G | Vanguard Group Inc | 5.24 | ||
| 13G | Fmr Llc | 6.05 | 114.74 | |
| 13G/A | Wellington Management Group Llp | 4.86 | 15.71 | |
| 13G/A | BlackRock Inc. | 8.00 | 36.44 | |
| 13G | State Street Corp | 5.34 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Form 10-K (Mark One) | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 65,808 | 474,219 | 13.88 | |
| 76,009 | 211,939 | 35.86 | |
| 81,369 | 507,335 | 16.04 | |
| 65,753 | 472,416 | 13.92 | |
| 86,586 | 540,700 | 16.01 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CPIX – Cumberland Pharmaceuticals Inc. | CRBU – Caribou Biosciences, Inc. |
| CRGX – CARGO Therapeutics, Inc. | CTMX – CytomX Therapeutics, Inc. |
| CYTK – Cytokinetics, Incorporated |
Financial data and stock pages provided by
Fintel.io